OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study
Dipal Mehta, Stephen Henderson, Jasmin Rahman, Emma Lyon, Elise Rees, Kane Foster, Daria Galas-Filipowicz, Catherine Olivier, Lorna Barnard, Kara-Louise Royle, Robert Cicero, Doina Levinte, Jonathan Clemmens, Ruth De Tute, Christopher Parrish, Mark Drayson, Ceri Bygrave, Dean Smith, Jonathan Sive, Guy Pratt, Kwee Yong
{"title":"OA-19 Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study","authors":"Dipal Mehta, Stephen Henderson, Jasmin Rahman, Emma Lyon, Elise Rees, Kane Foster, Daria Galas-Filipowicz, Catherine Olivier, Lorna Barnard, Kara-Louise Royle, Robert Cicero, Doina Levinte, Jonathan Clemmens, Ruth De Tute, Christopher Parrish, Mark Drayson, Ceri Bygrave, Dean Smith, Jonathan Sive, Guy Pratt, Kwee Yong","doi":"10.1016/S2152-2650(24)01860-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S13"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265024018603","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍：
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
